Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2026-01-09 @ 7:36 PM
Study NCT ID:
NCT00280059
Status:
COMPLETED
Last Update Posted:
2021-01-28
First Post:
2006-01-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-08
Start Date Type:
None
Primary Completion Date:
2009-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-04
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-18
First Submit QC Date:
None
Study First Post Date:
2006-01-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-12-16
Results First Submit QC Date:
None
Results First Post Date:
2011-10-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-26
Last Update Post Date:
2021-01-28
Last Update Post Date Type:
ACTUAL